Declining susceptibility to neomycin and polymyxin B of pathogens recovered in otitis externa clinical trialsCANTRELL, H. Furman; LOMBARDY, Elyane E; DUNCANSON, Frederick P et al.Southern medical journal (Birmingham). 2004, Vol 97, Num 5, pp 465-471, issn 0038-4348, 7 p.Article

New Trends in Polymyxin B Hemoperfusion: From 2006 to 2013CRUZ, Dinna N.Blood purification. 2014, Vol 37, pp 9-13, issn 0253-5068, 5 p., SUP1Article

Polymyxin B Hemoperfusion in Clinical Practice: The Picture from an Unbound Collaborative RegistryBlood purification. 2014, Vol 37, pp 22-25, issn 0253-5068, 4 p., SUP1Article

Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new?BERGEN, Phillip J; LANDERSDORFER, Cornelia B; JING ZHANG et al.Diagnostic microbiology and infectious disease. 2012, Vol 74, Num 3, pp 213-223, issn 0732-8893, 11 p.Article

Cation Concentration Variability of Four Distinct Mueller-Hinton Agar Brands Influences Polymyxin B Susceptibility ResultsGIRARDELLO, Raquel; BISPO, Paulo J. M; YAMANAKA, Tiago M et al.Journal of clinical microbiology (Print). 2012, Vol 50, Num 7, pp 2414-2418, issn 0095-1137, 5 p.Article

IMMUNOELECTROPHORETIC CHARACTERIZATION OF LIPOPOLYSACCHARIDES FROM SERRATIA MARCESCENS RESISTANT AND SENSITIVE TO POLYMYXIN B^AWEBER DA; TSANG JC.1975; TRANS. ILLINOIS STATE ACAD. SCI.; U.S.A.; DA. 1975; VOL. 68; NO 2; PP. 148-155; BIBL. 1 P.Article

LIPID CONTENT OF SERRATIA MARCESCENS, SENSITIVE AND RESISTANT TO POLYMYXIN B.WADE AE; TSANG JC.1975; TRANS. ILLINOIS STATE ACAD. SCI.; U.S.A.; DA. 1975; VOL. 68; NO 1; PP. 52-60; BIBL. 1 P. 1/2Article

VARIATION IN POLYMYXIN SENSITIVITY AMONG COLONIES IN PRIMARY PLATE CULTURES OF VIBRIO ELTORGUGNANI HC; PAL SC.1974; J. MED. MICROBIOL.; G.B.; DA. 1974; VOL. 7; NO 4; PP. 535-536; BIBL. 7REF.Article

CARE OF THE BURN WOUND WITH TOPICAL NEOSPORIN = LE TRAITEMENT DES BRULURES PAR LA NEOSPORINE LOCALEBUSH CA; STONE HH.1972; SOUTH. MED. J.; U.S.A.; DA. 1972; VOL. 65; NO 9; PP. 1083-1087; BIBL. 20 REF.Serial Issue

SELECTIVE BINDING OF POLYMYXIN B TO NEGATIVELY CHARGED LIPID MONOLAYERS.TEUBER M; MILLER IR.1977; BIOCHIM. BIOPHYS. ACTA; PAYS-BAS; DA. 1977; VOL. 467; NO 3; PP. 280-289; BIBL. 25 REF.Article

INACTIVATION OF ENDOTOXIN BY POLYMYXIN BCOOPERSTOCK MS.1974; ANTIMICROB. AGENTS CHEMOTHERAPY; U.S.A.; DA. 1974; VOL. 6; NO 4; PP. 422-425; BIBL. 27REF.Article

RELEASE OF CREATINE PHOSPHOKINASE FROM MUSCLE. II. EFFECT OF MULTIPLE DOSES OF POLYMYXIN B OR COMPOUND 48/80 ON INCREASES IN PLASMA ENZYME LEVELS = LA LIBERATION DE CREATINE-PHOSPHOKINASE DU MUSCLE. II. EFFET DE DOSES MULTIPLES DE POLYMYXINE B OU DU COMPOSE 48/80 SUR LES ACCROISSEMENTS DE L'ENZYME PLASMATIQUEMELTZER HY; MARGULIES P; HYONG WON CHO et al.1973; BIOCHEM. PHARMACOL.; G.B.; DA. 1973; VOL. 22; NO 7; PP. 857-863; BIBL. 14 REF.Serial Issue

Endotoxin Removal: History of a MissionRONCO, Claudio.Blood purification. 2014, Vol 37, pp 5-8, issn 0253-5068, 4 p., SUP1Article

Downregulation of RpoN-controlled genes protects Salmonella cells from killing by the cationic antimicrobial peptide polymyxin BBARCHIESI, Julieta; ESPARIZ, Martin; CHECA, Susana K et al.FEMS microbiology letters. 2009, Vol 291, Num 1, pp 73-79, issn 0378-1097, 7 p.Article

Modulation of P2X₇ receptor functions by polymyxin B : crucial role of the hydrophobic tail of the antibiotic moleculeFERRARI, D; PIZZIRANI, C; GULINELLI, S et al.British journal of pharmacology. 2007, Vol 150, Num 4, pp 445-454, issn 0007-1188, 10 p.Article

RELEASE OF PERIPLASMIC PROTEINS AND ENZYME ACTIVITIES BY POLYMYXIN B TREATMENT FROM SERRATIA MARCESCENSPAGE LV; TSANG JC.1975; MICROBIOS; G.B.; DA. 1975; VOL. 14; NO 55-56; PP. 7-21; BIBL. 1 P. 1/2Article

THE SECOND INTERNATIONAL STANDARD FOR POLYMYXIN BLIGHTBOWN JW; THOMAS AH; GRAB B et al.1973; BULL. ORGANISM. MOND. SANTE; SUISSE; DA. 1973; VOL. 48; NO 1; PP. 85-90; ABS. FR.; BIBL. 5REF.Serial Issue

COLUMN CHROMATOGRAPHIC DETERMINATION OF POLYMYXIN B SULFATEHAEMERS A; DE MOERLOOSE P.1972; J. PHARM. SCI.; U.S.A.; DA. 1972; VOL. 61; NO 11; PP. 1803-1805; BIBL. 12 REF.Serial Issue

THE DISTRIBUTION AND BINDING OF TRITIATED POLYMYXIN B IN THE MOUSEJOCOBSON M; KOCH A; KUNTZMAN R et al.1972; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1972; VOL. 183; NO 2; PP. 433-439; BIBL. 9 REF.Serial Issue

Contact dermatitis to polymyxin BJIARAVUTHISAN, M. M; DEKOVEN, J. G.Contact dermatitis. 2008, Vol 59, Num 5, pp 314-316, issn 0105-1873, 3 p.Article

Cytotoxicity and antigenicity of antimicrobial synthesized peptides derived from the beetle Allomyrina dichotoma defensin in miceKOYAMA, Yukari; MOTOBU, Maki; KANG, Chung-Boo et al.International immunopharmacology. 2006, Vol 6, Num 11, pp 1748-1753, issn 1567-5769, 6 p.Article

Ex-vivo evaluation of alginate microparticles for Polymyxin B oral administrationCOPPI, Gilberto; SALA, Nicoletta; BONDI, Moreno et al.Journal of drug targeting. 2006, Vol 14, Num 9, pp 599-606, issn 1061-186X, 8 p.Article

Improved bioluminescent enzyme immunoassay for the rapid detection of Salmonella in chicken meat samplesFUKUDA, S; TATSUMI, H; IGIMI, S et al.Letters in applied microbiology. 2005, Vol 41, Num 5, pp 379-384, issn 0266-8254, 6 p.Article

Changes in plasma interleukin-18 by direct hemoperfusion with polymyxin B-lmmobilized fiber in patients with septic shockNAKAMURA, Tsukasa; KAWAGOE, Yasuhiro; SUZUKIA, Tsukasa et al.Blood purification. 2005, Vol 23, Num 6, pp 417-420, issn 0253-5068, 4 p.Article

State of the Art in the Clinical Treatment of Endotoxic ShockARTIGAS, Antonio; PICCINNI, Pasquale.Blood purification. 2014, Vol 37, pp 2-4, issn 0253-5068, 3 p., SUP1Article